Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum
β Scribed by Andrew Burroughs; Daniel Hochhauser; Tim Meyer
- Book ID
- 117783222
- Publisher
- The Lancet
- Year
- 2004
- Tongue
- English
- Weight
- 758 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1470-2045
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The results obtained by liver transplantation (TX) (n = 105) for hepatocellular carcinoma (HCC) were compared with those achieved by hepatic resection (HX) (n = 76). Overall 1β to 5βyear survival rates after TX were 66%, 49%, 39%, 36%, and 36%, and those after HX were 71%, 55%, 47%, 37%
propranolol in the prevention of variceal re-bleeding: preliminary results hemodynamics, that may identify subgroups of patients at of a multicenter randomized trial [Abstract]. HEPATOLOGY 1995;22:297A. high risk for hepatic deterioration and early mortality precip-14. Jalan R, Forrest EH, Redhead D